Senolytics: Clearing the "Zombie Cells" That Drive Aging

What Is Cellular Senescence?

Cellular senescence is what happens when a cell exits its normal dividing cycle and gets stuck in a kind of biological limbo, no longer functional, but not dead either. We sometimes call these "zombie cells." They stop doing their job, and worse, they leak inflammatory signals that damage the healthy cells around them.

These cells accumulate in response to the wear and tear of daily life:

• Environmental toxins

• Refined sugars and ultra-processed foods

• Alcohol

• Radiation (including chronic sun exposure)

• Chronic inflammation and metabolic stress

This is a common thread running through a wide range of chronic illnesses from cardiovascular disease to neurodegeneration to osteoarthritis.

Are Senescent Cells Always Bad?

No 

Cellular senescence is actually a normal, protective biological process. It is one of your body's defenses against cancer: when a cell starts to acquire damage that could lead to malignant transformation, it can be pushed into the senescent state so it can't replicate uncontrollably. Your immune system is then supposed to come along and clear it out.

Senescence also plays a critical role in wound healing, where these cells temporarily orchestrate tissue repair before being removed.

So senescence itself isn't the enemy. The problem is the accumulation.

When Does It Become a Problem?

As we age, two things happen:

1. We produce more senescent cells.

2. The immune system loses its ability to efficiently clear them.

The result is a growing burden of these cells that the body can't keep up with. Through a process called paracrine activation, senescent cells release inflammatory signals that turn their healthy neighbors into senescent cells too  a kind of biological domino effect.

This drives chronic, low-grade, body-wide inflammation that researchers call "inflammaging." It's now understood to be a major underlying driver of premature aging and many age-related diseases.

What Do Senolytics Do?

Senolytics are a class of compounds designed to help the body do what the immune system used to do on its own, selectively eliminate senescent cells.

When used correctly, they work by:

• Exposing senescent cells to immune clearance

• Triggering a controlled form of cell death called apoptosis

The goal isn't to wipe out every senescent cell they still have a role to play  but to reduce the excess burden that's accelerating aging and driving disease.

What the Research Shows

Senolytics have been studied in a growing list of clinical trials, with particularly promising signals in cancer, Alzheimer's disease, and age-related decline.

Dasatinib and Quercetin (D+Q):
In a landmark human study, just three days of combined Dasatinib (a prescription medication) and Quercetin (a plant-derived compound) led to a significant reduction in senescent cells within 11 days. This combination has since been studied in:

• Idiopathic pulmonary fibrosis

• Bone health in postmenopausal women

• Alzheimer's disease

• Endothelial and vascular aging

• Epigenetic (biological) age markers

Fisetin:
In a foundational mouse study, just 5 days of Fisetin — a flavonoid found naturally in strawberries  reduced senescent cells across multiple tissues, restored tissue function, and reversed several age-related changes. Human trials are now underway in osteoarthritis, immune dysfunction, and frailty.

Is This Right for You?

Senolytics are a powerful and exciting tool, but they're not for everyone. We screen carefully before recommending them. In particular, these medications should be avoided in anyone with a bleeding disorder or bleeding tendency, and we evaluate each patient individually for drug interactions, kidney and liver function, and overall health status.

If senolytic therapy is appropriate for you, we'll discuss the protocol, expected timeline, and monitoring plan during your visit.